{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:29:13Z","timestamp":1769581753830,"version":"3.49.0"},"reference-count":198,"publisher":"Elsevier","isbn-type":[{"value":"9780323853156","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR13502\/MED\/30\/1555\/2015"],"award-info":[{"award-number":["BT\/PR13502\/MED\/30\/1555\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.apcsb.2020.08.001","type":"book-chapter","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T02:47:30Z","timestamp":1601520450000},"page":"121-147","source":"Crossref","is-referenced-by-count":12,"title":["Immunological and functional aspects of MAGEA3 cancer\/testis antigen"],"prefix":"10.1016","member":"78","reference":[{"issue":"2B","key":"10.1016\/bs.apcsb.2020.08.001_bb0010","first-page":"571","article-title":"Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail","volume":"24","author":"Akiyama","year":"2004","journal-title":"Anticancer Research"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2006-04-014480","article-title":"Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation","volume":"109","author":"Atanackovic","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3324\/haematol.2009.014464","article-title":"Cancer-testis antigens MAGE-C1\/CT7 and MAGE-A3 promote the survival of multiple myeloma cells","volume":"95","author":"Atanackovic","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CJI.0000000000000013","article-title":"Expression of MAGE-A3\/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survival","volume":"37","author":"Ayyoub","year":"2014","journal-title":"Journal of Immunotherapy"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.cji.0000171292.79663.cb","article-title":"Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon","volume":"28","author":"Banchereau","year":"2005","journal-title":"Journal of Immunotherapy"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0035","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00262-011-1037-z","article-title":"MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing","volume":"60","author":"Bao","year":"2011","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jnr.10160","article-title":"The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic disease","volume":"67","author":"Barker","year":"2002","journal-title":"Journal of Neuroscience Research"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0045","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.vaccine.2013.12.049","article-title":"Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector","volume":"32","author":"Batchu","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamasurg.2013.4113","article-title":"MAGE-A3 with cell-penetrating domain as an efficient therapeutic cancer vaccine","volume":"149","author":"Batchu","year":"2014","journal-title":"JAMA Surgery"},{"issue":"11","key":"10.1016\/bs.apcsb.2020.08.001_bb0055","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamasurg.2016.2346","article-title":"Pancreatic cancer cell lysis by cell-penetrating peptide-MAGE-A3-induced cytotoxic T lymphocytes","volume":"151","author":"Batchu","year":"2016","journal-title":"JAMA Surgery"},{"issue":"11","key":"10.1016\/bs.apcsb.2020.08.001_bb0060","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.192.11.1535","article-title":"Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells","volume":"192","author":"Berard","year":"2000","journal-title":"Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00001813-199804000-00004","volume":"9","author":"Bertram","year":"1998","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1399-0039.2002.600103.x","article-title":"A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18","volume":"60","author":"Bilsborough","year":"2002","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/jor.20368","article-title":"Lysis of human chondrosarcoma cells by cytolytic T lymphocytes recognizing a MAGE-A3 antigen presented by HLA-A1 molecules","volume":"25","author":"Bluman","year":"2007","journal-title":"Journal of Orthopaedic Research"},{"issue":"11","key":"10.1016\/bs.apcsb.2020.08.001_bb0080","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.4049\/jimmunol.172.11.6649","article-title":"Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules","volume":"172","author":"Bonehill","year":"2004","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0085","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1158\/1078-0432.CCR-08-2982","article-title":"Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients","volume":"15","author":"Bonehill","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"12","key":"10.1016\/bs.apcsb.2020.08.001_bb0090","first-page":"469","article-title":"Rejection antigens of tumors and specific immunotherapy of cancer","volume":"151","author":"Boon","year":"1996","journal-title":"Bulletin et M\u00e9moires de l'Acad\u00e9mie Royale de M\u00e9decine de Belgique"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0095","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"International Journal of Cancer"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0100","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jgm.400","article-title":"Lentivirally transduced dendritic cells as a tool for cancer immunotherapy","volume":"5","author":"Breckpot","year":"2003","journal-title":"The Journal of Gene Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0105","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4049\/jimmunol.172.4.2232","article-title":"Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses","volume":"172","author":"Breckpot","year":"2004","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CJI.0b013e3182829747","article-title":"Cancer regression and neurological toxicity cases after anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Brichard","year":"2013","journal-title":"Journal of Immunotherapy"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0115","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.4049\/jimmunol.180.5.3585","article-title":"Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells","volume":"180","author":"Carrasco","year":"2008","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0120","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/eji.200940123","article-title":"The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides","volume":"40","author":"Cecconi","year":"2010","journal-title":"European Journal of Immunology"},{"issue":"18","key":"10.1016\/bs.apcsb.2020.08.001_bb0125","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0161-5890(94)90158-9","article-title":"Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles","volume":"31","author":"Celis","year":"1994","journal-title":"Molecular Immunology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0130","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1073\/pnas.91.6.2105","article-title":"Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes","volume":"91","author":"Celis","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00262-010-0916-z","article-title":"MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: Detection of naturally acquired responses and identification of new epitopes","volume":"60","author":"Cesson","year":"2011","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1478-3231.1999.tb00019.x","article-title":"High frequency of expression of MAGE genes in human hepatocellular carcinoma","volume":"19","author":"Chen","year":"1999","journal-title":"Liver"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0145","first-page":"310","article-title":"Expression of MAGE-1 and MAGE-3 genes in gastric cancer and gastric biopsy tissues and its clinical significance","volume":"20","author":"Chen","year":"2004","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0150","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3892\/ol.2017.5665","article-title":"Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer","volume":"13","author":"Chen","year":"2017","journal-title":"Oncology Letters"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0155","first-page":"793","article-title":"Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma","volume":"32","author":"Chen","year":"2017","journal-title":"Histology and Histopathology"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0160","first-page":"974","article-title":"MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors","volume":"12","author":"Cheville","year":"1999","journal-title":"Modern Pathology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0165","first-page":"2143","article-title":"Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas","volume":"150","author":"Chi","year":"1997","journal-title":"American Journal of Pathology"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.1001775","article-title":"A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer","volume":"186","author":"Chinnasamy","year":"2011","journal-title":"Journal of Immunology"},{"issue":"3 Suppl. 1","key":"10.1016\/bs.apcsb.2020.08.001_bb0175","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.surg.2012.05.031","article-title":"Targeting the MAGE A3 antigen in pancreatic cancer","volume":"152","author":"Cogdill","year":"2012","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nature Review of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0185","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood-2002-03-0933","article-title":"Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3","volume":"101","author":"Consogno","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1097-0215(19961021)69:5<403::AID-IJC9>3.0.CO;2-9","article-title":"Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma","volume":"69","author":"Corrias","year":"1996","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1600-065X.2002.18804.x","article-title":"Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen","volume":"188","author":"Coulie","year":"2002","journal-title":"Immunological Reviews"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0200","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/0008-5472.CAN-04-1882","article-title":"Cancer\/testis antigen expression in human mesenchymal stem cells: Down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression","volume":"65","author":"Cronwright","year":"2005","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ijc.1307","article-title":"MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas","volume":"93","author":"Dalerba","year":"2001","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13046-019-1272-2","article-title":"Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells","volume":"38","author":"Das","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0215","first-page":"28","article-title":"MAGEA3 (melanoma antigen family A, 3)","volume":"19","author":"Das","year":"2014","journal-title":"Atlas of Genetics and Cytogenetics in Oncology and Haematology"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01246677","article-title":"Structure, chromosomal localization, and expression of 12 genes of the MAGE family","volume":"40","author":"De Plaen","year":"1994","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/fon.13.166","article-title":"Immunotherapy for lung cancer: Ongoing clinical trials","volume":"10","author":"Declerck","year":"2014","journal-title":"Future Oncology"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0230","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1078-0432.CCR-16-1189","article-title":"Intravesical Bacillus Calmette Guerin combined with a cancer vaccine increases local T-cell responses in non-muscle-invasive bladder cancer patients","volume":"23","author":"Derre","year":"2017","journal-title":"Clinical Cancer Research"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jat.3025","article-title":"Non-clinical safety evaluation of single and repeated intramuscular administrations of MAGE-A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys","volume":"35","author":"Destexhe","year":"2015","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0240","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.reprotox.2014.12.009","article-title":"Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 cancer Immunotherapeutic, a therapeutic vaccine for cancer treatment","volume":"51","author":"Destexhe","year":"2015","journal-title":"Reproductive Toxicology"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20011097","article-title":"Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells","volume":"195","author":"Dhodapkar","year":"2002","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0250","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1006\/bbrc.1994.1963","article-title":"Cloning and analysis of MAGE-1-related genes","volume":"202","author":"Ding","year":"1994","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0255","first-page":"2778","article-title":"Overexpression of MAGE\/GAGE genes in paclitaxel\/doxorubicin-resistant human cancer cell lines","volume":"9","author":"Duan","year":"2003","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0260","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ymthe.2004.07.017","article-title":"Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: Implications for cancer immunotherapy protocols","volume":"10","author":"Dullaers","year":"2004","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-3083.2008.02202.x","article-title":"Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes","volume":"69","author":"Durantez","year":"2009","journal-title":"Scandinavian Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bjc.2012.215","article-title":"Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma","volume":"107","author":"Dyrskjot","year":"2012","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/PL00012077","article-title":"Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes","volume":"6","author":"Eifuku","year":"2001","journal-title":"International Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0280","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/imt.15.29","article-title":"MAGE-A3: An immunogenic target used in clinical practice","volume":"7","author":"Esfandiary","year":"2015","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0285","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1023\/A:1008255630202","article-title":"Expression of MAGE and BAGE genes in Japanese breast cancers","volume":"8","author":"Fujie","year":"1997","journal-title":"Annals of Oncology"},{"issue":"12 Pt. 1","key":"10.1016\/bs.apcsb.2020.08.001_bb0290","first-page":"2425","article-title":"Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro","volume":"3","author":"Fujie","year":"1997","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0295","first-page":"754","article-title":"Melanoma-associated tumor antigens and their clinical relevance to immunotherapy","volume":"23","author":"Gattoni-Celli","year":"1996","journal-title":"Seminars in Oncology"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0300","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.179.3.921","article-title":"Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes","volume":"179","author":"Gaugler","year":"1994","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094883","article-title":"Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses","volume":"9","author":"Gerard","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0310","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood-2008-04-149393","article-title":"Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1\/A2\/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma","volume":"112","author":"Goodyear","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0315","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.169.1.575","article-title":"Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: Implication in a broad-spectrum tumor immunotherapy","volume":"169","author":"Graff-Dubois","year":"2002","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/ol.2013.1351","article-title":"The expression and clinical significance of melanoma-associated antigen-A1, -A3 and -A11 in glioma","volume":"6","author":"Guo","year":"2013","journal-title":"Oncology Letters"},{"issue":"22","key":"10.1016\/bs.apcsb.2020.08.001_bb0325","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1158\/1078-0432.CCR-05-1203","article-title":"Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer","volume":"11","author":"Gure","year":"2005","journal-title":"Clinical Cancer Research"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0330","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.leukres.2009.11.028","article-title":"Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood","volume":"34","author":"Han","year":"2010","journal-title":"Leukemia Research"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0335","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00262-004-0587-8","article-title":"Phase I\/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma","volume":"54","author":"Hersey","year":"2005","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00262-003-0429-0","article-title":"Phase I\/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma","volume":"53","author":"Hersey","year":"2004","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0345","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.rmr.2010.08.002","article-title":"Molecular biology of lung cancer series","volume":"27","author":"Hiret","year":"2010","journal-title":"Revue des Maladies Respiratoires"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0350","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00262-013-1438-2","article-title":"Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients","volume":"62","author":"Hobo","year":"2013","journal-title":"Cancer Immunology and Immunotherapy"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0355","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(95)90639-8","article-title":"The expression of tumor-rejection antigen \"MAGE\" genes in human gastric carcinoma","volume":"109","author":"Inoue","year":"1995","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0360","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ijc.2910630411","article-title":"Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes","volume":"63","author":"Inoue","year":"1995","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0365","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19961021)69:5<375::AID-IJC4>3.0.CO;2-2","article-title":"MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-related pediatric solid tumors","volume":"69","author":"Ishida","year":"1996","journal-title":"International Journal of Cancer"},{"issue":"16","key":"10.1016\/bs.apcsb.2020.08.001_bb0370","first-page":"4446","article-title":"Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis","volume":"60","author":"Jenne","year":"2000","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0375","first-page":"2160","article-title":"Antitumor effect of recombinant Mycobacterium smegmatis expressing MAGEA3 and SSX2 fusion proteins","volume":"16","author":"Jian","year":"2018","journal-title":"Experimenatal and Therapeutic Medicine"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0380","article-title":"MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation","volume":"6","author":"Jin","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0385","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2004-12-4931","article-title":"The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3\/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation","volume":"106","author":"Jungbluth","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0390","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-9098(199905)71:1<16::AID-JSO4>3.0.CO;2-A","article-title":"Induction of human leukocyte antigen (HLA)-A2-restricted and MAGE-3-gene-derived peptide-specific cytolytic T lymphocytes using cultured dendritic cells from an HLA-A2 esophageal cancer patient","volume":"71","author":"Kanaoka","year":"1999","journal-title":"Journal of Surgical Oncology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0395","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/sj.bjc.6690810","article-title":"Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma","volume":"81","author":"Kariyama","year":"1999","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0400","first-page":"174","article-title":"Rational development of peptide vaccination in clinical oncology","volume":"24","author":"Keiholz","year":"2001","journal-title":"Onkologie"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0405","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3346\/jkms.2001.16.1.62","article-title":"Expression of MAGE-1, -2, and -3 genes in gastric carcinomas and cancer cell lines derived from Korean patients","volume":"16","author":"Kim","year":"2001","journal-title":"Journal of Korean Medical Science"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0410","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/ijc.21656","article-title":"The clinical significance of MAGEA3 expression in pancreatic cancer","volume":"118","author":"Kim","year":"2006","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0415","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0168-8278(00)80223-8","article-title":"Expression of MAGE, GAGE and BAGE genes in human liver diseases: Utility as molecular markers for hepatocellular carcinoma","volume":"32","author":"Kobayashi","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1016\/bs.apcsb.2020.08.001_bb0420","first-page":"4773","article-title":"Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles","volume":"61","author":"Kobayashi","year":"2001","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0425","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1007\/s13277-014-1764-9","article-title":"Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1","volume":"35","author":"Krishnadas","year":"2014","journal-title":"Tumour Biology"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0430","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00262-015-1731-3","article-title":"A phase I trial combining decitabine\/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma","volume":"64","author":"Krishnadas","year":"2015","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0435","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000493577","article-title":"Strong expression of cancer testis antigens CTAG1B and MAGEA3 is correlated with unfavourable histopathological features and MAGEA3 is associated with worse progression-free survival in urothelial bladder cancer","volume":"102","author":"Lausenmeyer","year":"2019","journal-title":"Urologia Internationalis"},{"issue":"6B","key":"10.1016\/bs.apcsb.2020.08.001_bb0440","first-page":"5037","article-title":"Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck","volume":"19","author":"Lee","year":"1999","journal-title":"Anticancer Research"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0445","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00262-003-0390-y","article-title":"Injection by various routes of melanoma antigen-associated macrophages: Biodistribution and clinical effects","volume":"52","author":"Lesimple","year":"2003","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"3","key":"10.1016\/bs.apcsb.2020.08.001_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4238\/gmr.15039001","article-title":"Enhancement of dendritic cells with melanoma-associated antigen 3 for inducing cytotoxicity by cytotoxic T lymphocytes on bladder cancer BIU-87 cells","volume":"15","author":"Li","year":"2016","journal-title":"Genetics and Molecular Research"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0455","first-page":"1619","article-title":"Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma","volume":"2","author":"Li","year":"1996","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0460","doi-asserted-by":"crossref","first-page":"795239","DOI":"10.4061\/2011\/795239","article-title":"Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks","volume":"2011","author":"Lifantseva","year":"2011","journal-title":"Stem Cells International"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0465","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00432-013-1552-8","article-title":"Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene","volume":"140","author":"Lin","year":"2014","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0470","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"issue":"19","key":"10.1016\/bs.apcsb.2020.08.001_bb0475","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1158\/0008-5472.CAN-08-2132","article-title":"The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis","volume":"68","author":"Liu","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0480","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cellimm.2015.12.003","article-title":"Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells","volume":"300","author":"Liu","year":"2016","journal-title":"Cellular Immunology"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0485","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2015.03.011","article-title":"Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens","volume":"295","author":"Liu","year":"2015","journal-title":"Cellular Immunology"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0490","first-page":"138","article-title":"Expression of MAGE-3 gene product in non-small cell lung cancer","volume":"22","author":"Liu","year":"2000","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046928","article-title":"IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma","volume":"7","author":"Lorenzi","year":"2012","journal-title":"PLoS One"},{"issue":"30","key":"10.1016\/bs.apcsb.2020.08.001_bb0500","first-page":"2120","article-title":"Inhibitory effect of dendritic cells pulsed with MAGE-3 peptide on transplanted murine gastric cancer in mice","volume":"85","author":"Lu","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"29","key":"10.1016\/bs.apcsb.2020.08.001_bb0505","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1200\/JCO.2017.74.5463","article-title":"Treatment of patients with metastatic cancer using a major histocompatibility complex class II-restricted T-cell receptor targeting the cancer germline antigen MAGE-A3","volume":"35","author":"Lu","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0510","first-page":"159","article-title":"Expression of MAGE genes and MAGE gene products in human renal and urinary bladder tumor","volume":"36","author":"Ma","year":"2004","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0515","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2310\/JIM.0b013e31822a2360","article-title":"Melanoma antigen encoding gene-A3 expression, its clinical significance, and its risk of developing acute myeloid leukemia","volume":"59","author":"Makhlouf","year":"2011","journal-title":"Journal of Investigative Medicine"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0520","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc.2016.66","article-title":"Pancreatic cancer biology and genetics from an evolutionary perspective","volume":"16","author":"Makohon-Moore","year":"2016","journal-title":"Nature Reviews Cancer"},{"issue":"24","key":"10.1016\/bs.apcsb.2020.08.001_bb0525","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1158\/0008-5472.CAN-10-1341","article-title":"Mage-A cancer\/testis antigens inhibit p53 function by blocking its interaction with chromatin","volume":"70","author":"Marcar","year":"2010","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0530","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S","article-title":"Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1","volume":"80","author":"Marchand","year":"1999","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0535","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.leukres.2006.05.009","article-title":"mRNA expression of MAGE-A3 gene in leukemia cells","volume":"31","author":"Martinez","year":"2007","journal-title":"Leukemia Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0540","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/EP:17:1:45","article-title":"Expression of MAGE tumor-associated antigen in thyroid carcinomas","volume":"17","author":"Milkovic","year":"2006","journal-title":"Endocrine Pathology"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0545","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000089994","article-title":"Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA","volume":"69","author":"Minami","year":"2005","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0550","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.leukres.2010.03.045","article-title":"MAGE, biological functions and potential clinical applications","volume":"34","author":"Miranda","year":"2010","journal-title":"Leukemia Research"},{"issue":"11","key":"10.1016\/bs.apcsb.2020.08.001_bb0555","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00262-012-1272-y","article-title":"Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naive T-cell subtypes","volume":"61","author":"Moeller","year":"2012","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"30","key":"10.1016\/bs.apcsb.2020.08.001_bb0560","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.1073\/pnas.0510834103","article-title":"MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents","volume":"103","author":"Monte","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0565","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/14653249.2010.529893","article-title":"Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetylase inhibitor MGCD0103","volume":"13","author":"Moreno-Bost","year":"2011","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0570","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"Journal of Immunotherapy"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0575","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000658-199608000-00011","article-title":"Expression of MAGE genes in human colorectal carcinoma","volume":"224","author":"Mori","year":"1996","journal-title":"Annals of Surgery"},{"issue":"37","key":"10.1016\/bs.apcsb.2020.08.001_bb0580","doi-asserted-by":"crossref","first-page":"34287","DOI":"10.1074\/jbc.M204973200","article-title":"An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12","volume":"277","author":"Morishima","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"13","key":"10.1016\/bs.apcsb.2020.08.001_bb0585","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-10-1820","article-title":"MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin","volume":"17","author":"Nardiello","year":"2011","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0590","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2177\/jsci.20.95","article-title":"Expression of MAGE genes in colorectal carcinomas","volume":"20","author":"Nishimura","year":"1997","journal-title":"Nihon Rinsh\u014d Men'eki Gakkai Kaishi"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0595","first-page":"23","article-title":"Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide","volume":"7","author":"Nishiyama","year":"2001","journal-title":"Clinical Cancer Reseach"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0600","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1179\/102453311X13085644680384","article-title":"MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma","volume":"16","author":"Olarte","year":"2011","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0605","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/10430340050015635","article-title":"Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line","volume":"11","author":"Osanto","year":"2000","journal-title":"Human Gene Therapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0610","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3892\/or.2012.1956","article-title":"Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial","volume":"28","author":"Oshita","year":"2012","journal-title":"Oncology Reports"},{"issue":"18","key":"10.1016\/bs.apcsb.2020.08.001_bb0615","first-page":"6682","article-title":"MAGE-A gene expression pattern in primary breast cancer","volume":"61","author":"Otte","year":"2001","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0620","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/1750743X.1.1.19","article-title":"MAGE A3 antigen-specific cancer immunotherapeutic","volume":"1","author":"Peled","year":"2009","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0625","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1080\/15548627.2015.1034420","article-title":"Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer","volume":"11","author":"Pineda","year":"2015","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0630","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cell.2015.01.034","article-title":"Degradation of AMPK by a cancer-specific ubiquitin ligase","volume":"160","author":"Pineda","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0635","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1512329","article-title":"Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials","volume":"8","author":"Pol","year":"2019","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0640","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/JTO.0000000000000653","article-title":"Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with or without adjuvant chemotherapy in patients with resected stage IB to III MAGE-A3-positive non-small-cell lung cancer","volume":"10","author":"Pujol","year":"2015","journal-title":"Journal of Thoracic Oncology"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0645","first-page":"436","article-title":"A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis","volume":"48","author":"Qu","year":"2010","journal-title":"Indian Journal of Experimental Biology"},{"issue":"1A","key":"10.1016\/bs.apcsb.2020.08.001_bb0650","first-page":"387","article-title":"Expression of MAGE genes in esophageal squamous-cell carcinoma","volume":"17","author":"Quillien","year":"1997","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0655","doi-asserted-by":"crossref","first-page":"18851","DOI":"10.1038\/srep18851","article-title":"Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy","volume":"6","author":"Raman","year":"2016","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/bs.apcsb.2020.08.001_bb0660","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1158\/0008-5472.CAN-10-2442","article-title":"Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: Implications for adoptive immunotherapy of cancer","volume":"71","author":"Rao","year":"2011","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0665","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1078-0432.CCR-13-2817","article-title":"Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3\/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells","volume":"20","author":"Rapoport","year":"2014","journal-title":"Clinical Cancer Research"},{"issue":"Suppl. 8","key":"10.1016\/bs.apcsb.2020.08.001_bb0670","doi-asserted-by":"crossref","first-page":"viii28","DOI":"10.1093\/annonc\/mds260","article-title":"What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?","volume":"23","author":"Reck","year":"2012","journal-title":"Annals of Oncology"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2020.08.001_bb0675","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(00)00254-4","article-title":"Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis","volume":"244","author":"Reynolds","year":"2000","journal-title":"Journal of Immunological Methods"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0680","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1155\/2009\/510124","article-title":"A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma","volume":"27","author":"Ries","year":"2009","journal-title":"Disease Markers"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0685","first-page":"2277","article-title":"Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas","volume":"7","author":"Sadanaga","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0690","first-page":"3916","article-title":"Expression of cancer testis genes in human brain tumors","volume":"6","author":"Sahin","year":"2000","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0695","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/annonc\/mdw291","article-title":"Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)","volume":"27","author":"Saiag","year":"2016","journal-title":"Annals of Oncology"},{"issue":"12","key":"10.1016\/bs.apcsb.2020.08.001_bb0700","first-page":"5023","article-title":"Cancer\/Testis antigen expression on mesenchymal stem cells isolated from different tissues","volume":"30","author":"Saldanha-Araujo","year":"2010","journal-title":"Anticancer Research"},{"issue":"47","key":"10.1016\/bs.apcsb.2020.08.001_bb0705","doi-asserted-by":"crossref","first-page":"8496","DOI":"10.1016\/j.vaccine.2011.09.014","article-title":"MAGE-A family: Attractive targets for cancer immunotherapy","volume":"29","author":"Sang","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0710","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.174.5.3087","article-title":"Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation","volume":"174","author":"Schaft","year":"2005","journal-title":"Journal of Immunology"},{"issue":"22","key":"10.1016\/bs.apcsb.2020.08.001_bb0715","first-page":"6272","article-title":"A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes","volume":"60","author":"Schultz","year":"2000","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0720","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1034\/j.1399-0039.2001.057002103.x","article-title":"A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes","volume":"57","author":"Schultz","year":"2001","journal-title":"Tissue Antigens"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0725","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nrgastro.2017.182","article-title":"Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options","volume":"15","author":"Semaan","year":"2018","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0730","first-page":"16","article-title":"MAGE-A3 is highly expressed in a subset of colorectal cancer patients","volume":"12","author":"Shantha Kumara","year":"2012","journal-title":"Cancer Immunity"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejcts.2003.09.015","article-title":"Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: Results of a multi-center study","volume":"25","author":"Sienel","year":"2004","journal-title":"European Journal of Cardiothoracic Surgery"},{"issue":"3B","key":"10.1016\/bs.apcsb.2020.08.001_bb0740","first-page":"2205","article-title":"Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma","volume":"19","author":"Soling","year":"1999","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0745","doi-asserted-by":"crossref","first-page":"586314","DOI":"10.1155\/2012\/586314","article-title":"TCR gene transfer: MAGE-C2\/HLA-A2 and MAGE-A3\/HLA-DP4 epitopes as melanoma-specific immune targets","volume":"2012","author":"Straetemans","year":"2012","journal-title":"Clinical & Developmental Immunology"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0750","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jor.1100150119","article-title":"Expression of MAGE genes in osteosarcoma","volume":"15","author":"Sudo","year":"1997","journal-title":"Journal of Orthopaedic Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0755","first-page":"1227","article-title":"Expression of MAGE genes and survival in patients with hepatocellular carcinoma","volume":"15","author":"Suzuki","year":"1999","journal-title":"International Journal of Oncology"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0760","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jocn.2011.10.008","article-title":"Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma","volume":"19","author":"Syed","year":"2012","journal-title":"Journal of Clinical Neuroscience"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0765","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12032-017-1035-x","article-title":"Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients","volume":"34","author":"Taborska","year":"2017","journal-title":"Medical Oncology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0770","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1234::AID-CNCR4>3.0.CO;2-7","article-title":"Expression of the MAGE gene family in human hepatocellular carcinoma","volume":"85","author":"Tahara","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0775","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(03)00244-7","article-title":"Expression of cancer\/testis (CT) antigens in lung cancer","volume":"42","author":"Tajima","year":"2003","journal-title":"Lung Cancer"},{"issue":"20","key":"10.1016\/bs.apcsb.2020.08.001_bb0780","first-page":"4465","article-title":"Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24","volume":"57","author":"Tanaka","year":"1997","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0785","first-page":"1111","article-title":"Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas","volume":"20","author":"Tanaka","year":"2008","journal-title":"Oncology Reports"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0790","first-page":"1263","article-title":"Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes","volume":"29","author":"Tanaka","year":"2006","journal-title":"International Journal of Oncology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0795","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00262-003-0484-6","article-title":"Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies","volume":"53","author":"Tanzarella","year":"2004","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0800","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/S1470-2045(12)70126-2","article-title":"Immunotherapies for non-small-cell lung cancer and mesothelioma","volume":"13","author":"Thomas","year":"2012","journal-title":"Lancet Oncology"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0805","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.lungcan.2016.09.006","article-title":"The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients","volume":"101","author":"Thongprasert","year":"2016","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0810","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1051\/jbio\/2001195010019","article-title":"Anti-tumor immunotherapy based on dendritic cells","volume":"195","author":"Toungouz","year":"2001","journal-title":"Journal de la Societe de biologie"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0815","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1189\/jlb.69.6.937","article-title":"Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1\/A3-positive tumors","volume":"69","author":"Toungouz","year":"2001","journal-title":"Journal of Leukocyte Biology"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0820","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.cgt.7700804","article-title":"Immune characterization of clinical grade-dendritic cells generated from cancer patients and genetically modified by an ALVAC vector carrying MAGE minigenes","volume":"12","author":"Trakatelli","year":"2005","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0825","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-3338-9_9","article-title":"T Cells as Antigen Carriers for Anti-tumor Vaccination","volume":"1393","author":"Traversari","year":"2016","journal-title":"Methods in Molecular Biology"},{"issue":"5","key":"10.1016\/bs.apcsb.2020.08.001_bb0830","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3816\/CLC.2009.n.052","article-title":"MAGRIT: The largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy","volume":"10","author":"Tyagi","year":"2009","journal-title":"Clinical Lung Cancer"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0835","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jjco\/hyl136","article-title":"Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides","volume":"37","author":"Ueda","year":"2007","journal-title":"Japanese Journal of Clinical Oncology"},{"issue":"19","key":"10.1016\/bs.apcsb.2020.08.001_bb0840","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2012.44.3762","article-title":"Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy","volume":"31","author":"Ulloa-Montoya","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0845","first-page":"735","article-title":"Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients","volume":"57","author":"Valmori","year":"1997","journal-title":"Cancer Research"},{"issue":"12","key":"10.1016\/bs.apcsb.2020.08.001_bb0850","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1002\/eji.1830241218","article-title":"A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3","volume":"24","author":"van der Bruggen","year":"1994","journal-title":"European Journal of Immunology"},{"issue":"5038","key":"10.1016\/bs.apcsb.2020.08.001_bb0855","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0860","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-065X.1995.tb00084.x","article-title":"Genes coding for tumor antigens recognized by cytolytic T lymphocytes","volume":"145","author":"Van Pel","year":"1995","journal-title":"Immunological Reviews"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0865","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncology"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0870","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00002371-200403000-00006","article-title":"Immunologic analysis of a phase I\/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors","volume":"27","author":"Vantomme","year":"2004","journal-title":"Journal of Immunotherapy"},{"issue":"28","key":"10.1016\/bs.apcsb.2020.08.001_bb0875","doi-asserted-by":"crossref","first-page":"46047","DOI":"10.18632\/oncotarget.17517","article-title":"Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells","volume":"8","author":"Vo","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0880","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00403-009-0944-8","article-title":"Melanoma gene expression and clinical course","volume":"301","author":"Vourc'h-Jourdain","year":"2009","journal-title":"Archives of Dermatological Research"},{"issue":"14","key":"10.1016\/bs.apcsb.2020.08.001_bb0885","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.7150\/ijms.27643","article-title":"Cancer\/testis Antigen MAGEA3 Interacts with STAT1 and remodels the tumor microenvironment","volume":"15","author":"Wang","year":"2018","journal-title":"International Journal of Medical Sciences"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0890","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1054\/bjoc.2001.2079","article-title":"Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes","volume":"85","author":"Wascher","year":"2001","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0895","first-page":"9","article-title":"Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine","volume":"9","author":"Weinert","year":"2009","journal-title":"Cancer Immunity"},{"issue":"Suppl. 1","key":"10.1016\/bs.apcsb.2020.08.001_bb0900","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.3816\/CLC.2009.s.007","article-title":"Novel targeted agents for lung cancer","volume":"10","author":"West","year":"2009","journal-title":"Clinical Lung Cancer"},{"issue":"10","key":"10.1016\/bs.apcsb.2020.08.001_bb0905","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/annonc\/mdt245","article-title":"A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients","volume":"24","author":"Wilgenhof","year":"2013","journal-title":"Annals of Oncology"},{"issue":"37","key":"10.1016\/bs.apcsb.2020.08.001_bb0910","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/onc.2014.45","article-title":"Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer","volume":"33","author":"Wong","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.07.031","article-title":"miR-1273g silences MAGEA3\/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling","volume":"435","author":"Wu","year":"2018","journal-title":"Cancer Letters"},{"issue":"19","key":"10.1016\/bs.apcsb.2020.08.001_bb0920","first-page":"E4453","article-title":"Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells","volume":"115","author":"Wu","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.apcsb.2020.08.001_bb0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023747","article-title":"MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression","volume":"6","author":"Xiao","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0930","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13402-015-0261-5","article-title":"Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer","volume":"39","author":"Xie","year":"2016","journal-title":"Cellular Oncology (Dordrecht)"},{"issue":"20","key":"10.1016\/bs.apcsb.2020.08.001_bb0935","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1158\/0008-5472.CAN-07-1478","article-title":"MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/bs.apcsb.2020.08.001_bb0940","first-page":"2934","article-title":"MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells","volume":"7","author":"Yin","year":"2014","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0945","first-page":"4112","article-title":"Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma","volume":"7","author":"Yin","year":"2014","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"2","key":"10.1016\/bs.apcsb.2020.08.001_bb0950","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1096-9098(199802)67:2<126::AID-JSO10>3.0.CO;2-1","article-title":"Expression of the melanoma antigen-encoding gene in human lung cancer","volume":"67","author":"Yoshimatsu","year":"1998","journal-title":"Journal of Surgical Oncology"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0955","first-page":"197","article-title":"A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor T helper and CTL responses","volume":"61","author":"You","year":"2001","journal-title":"Cancer Research"},{"issue":"12","key":"10.1016\/bs.apcsb.2020.08.001_bb0960","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00262-007-0338-8","article-title":"Specific CD8(+)T cell responses to HLA-A2 restricted MAGE-A3 p271-279 peptide in hepatocellular carcinoma patients without vaccination","volume":"56","author":"Zhang","year":"2007","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"4","key":"10.1016\/bs.apcsb.2020.08.001_bb0965","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/eji.200425847","article-title":"A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells","volume":"35","author":"Zhang","year":"2005","journal-title":"European Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0970","first-page":"245","article-title":"The anti-tumor immune response induced by a combination of MAGE-3\/MAGE-n-derived peptides","volume":"20","author":"Zhang","year":"2008","journal-title":"Oncology Reports"},{"key":"10.1016\/bs.apcsb.2020.08.001_bb0975","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2407-10-163","article-title":"Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines","volume":"10","author":"Zhang","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2020.08.001_bb0980","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.imlet.2005.02.007","article-title":"Identification of two naturally presented MAGE antigenic peptides from a patient with hepatocellular carcinoma by mass spectrometry","volume":"99","author":"Zhou","year":"2005","journal-title":"Immunology Letters"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0985","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/1078-0432.CCR-07-2003","article-title":"Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia","volume":"14","author":"Zhu","year":"2008","journal-title":"Clinical Cancer Research"},{"issue":"9","key":"10.1016\/bs.apcsb.2020.08.001_bb0990","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/CJI.0b013e31827338ea","article-title":"Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12","volume":"35","author":"Zhu","year":"2012","journal-title":"Journal of Immunotherapy"},{"issue":"7","key":"10.1016\/bs.apcsb.2020.08.001_bb0995","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/cncr.26486","article-title":"Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis","volume":"118","author":"Zou","year":"2012","journal-title":"Cancer"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Apoptosis in Health and Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162320300584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162320300584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:17:21Z","timestamp":1761754641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162320300584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323853156"],"references-count":198,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2020.08.001","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}